375 related articles for article (PubMed ID: 28812216)
1. An overview of in vitro and in vivo glycation of albumin: a potential disease marker in diabetes mellitus.
Neelofar K; Ahmad J
Glycoconj J; 2017 Oct; 34(5):575-584. PubMed ID: 28812216
[TBL] [Abstract][Full Text] [Related]
2. Non-enzymatic glucosylation induced neo-epitopes on human serum albumin: A concentration based study.
Neelofar K; Arif Z; Ahmad J; Alam K
PLoS One; 2017; 12(2):e0172074. PubMed ID: 28192530
[TBL] [Abstract][Full Text] [Related]
3. Elucidating the impact of glucosylation on human serum albumin: A multi-technique approach.
Neelofar KM; Ahmad J; Arif Z; Alam K
Int J Biol Macromol; 2016 Nov; 92():881-891. PubMed ID: 27492562
[TBL] [Abstract][Full Text] [Related]
4. Glycated albumin in diabetic patients with chronic kidney disease.
Zheng CM; Ma WY; Wu CC; Lu KC
Clin Chim Acta; 2012 Oct; 413(19-20):1555-61. PubMed ID: 22579765
[TBL] [Abstract][Full Text] [Related]
5. The clinical usefulness of glycated albumin in patients with diabetes and chronic kidney disease: Progress and challenges.
Gan T; Liao B; Xu G
J Diabetes Complications; 2018 Sep; 32(9):876-884. PubMed ID: 30049445
[TBL] [Abstract][Full Text] [Related]
6. Review: Glycation of human serum albumin.
Anguizola J; Matsuda R; Barnaby OS; Hoy KS; Wa C; DeBolt E; Koke M; Hage DS
Clin Chim Acta; 2013 Oct; 425():64-76. PubMed ID: 23891854
[TBL] [Abstract][Full Text] [Related]
7. Nonenzymatic glycosylation of human serum albumin and its effect on antibodies profile in patients with diabetes mellitus.
Raghav A; Ahmad J; Alam K
PLoS One; 2017; 12(5):e0176970. PubMed ID: 28520799
[TBL] [Abstract][Full Text] [Related]
8. Effects of non-enzymatic glycation in human serum albumin. Spectroscopic analysis.
Szkudlarek A; Sułkowska A; Maciążek-Jurczyk M; Chudzik M; Równicka-Zubik J
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jan; 152():645-53. PubMed ID: 25735846
[TBL] [Abstract][Full Text] [Related]
9. Glycated Serum Albumin and AGE Receptors.
Vetter SW
Adv Clin Chem; 2015; 72():205-75. PubMed ID: 26471084
[TBL] [Abstract][Full Text] [Related]
10. Role of early glycation Amadori products of lysine-rich proteins in the production of autoantibodies in diabetes type 2 patients.
Ansari NA; Moinuddin ; Mir AR; Habib S; Alam K; Ali A; Khan RH
Cell Biochem Biophys; 2014 Nov; 70(2):857-65. PubMed ID: 24789546
[TBL] [Abstract][Full Text] [Related]
11. Glycated serum albumin: a potential disease marker and an intermediate index of diabetes control.
Raghav A; Ahmad J
Diabetes Metab Syndr; 2014; 8(4):245-51. PubMed ID: 25311816
[TBL] [Abstract][Full Text] [Related]
12. Recent topics in chemical and clinical research on glycated albumin.
Ueda Y; Matsumoto H
J Diabetes Sci Technol; 2015 Mar; 9(2):177-82. PubMed ID: 25614014
[TBL] [Abstract][Full Text] [Related]
13. Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries.
Schalkwijk CG; Ligtvoet N; Twaalfhoven H; Jager A; Blaauwgeers HG; Schlingemann RO; Tarnow L; Parving HH; Stehouwer CD; van Hinsbergh VW
Diabetes; 1999 Dec; 48(12):2446-53. PubMed ID: 10580435
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycemia induced structural and functional changes in human serum albumin of diabetic patients: a physico-chemical study.
Neelofar K; Arif Z; Alam K; Ahmad J
Mol Biosyst; 2016 Jul; 12(8):2481-9. PubMed ID: 27226040
[TBL] [Abstract][Full Text] [Related]
15. Structural and immunological characterization of Amadori-rich human serum albumin: role in diabetes mellitus.
Arif B; Ashraf JM; Moinuddin ; Ahmad J; Arif Z; Alam K
Arch Biochem Biophys; 2012 Jun; 522(1):17-25. PubMed ID: 22516656
[TBL] [Abstract][Full Text] [Related]
16. Albumin Oxidation and Albumin Glycation Discordance During Type 2 Diabetes Therapy: Biological and Clinical Implications.
Vaishnav MS; Kumari N; Srikanta S; Simha V; Krishnaswamy PR; Balaram P; Bhat N
Metab Syndr Relat Disord; 2024 Jun; 22(5):372-384. PubMed ID: 38696648
[No Abstract] [Full Text] [Related]
17. Influence of Piracetam on Gliclazide-Glycated Human Serum Albumin Interaction. A Spectrofluorometric Study.
Szkudlarek A; Pożycka J; Maciążek-Jurczyk M
Molecules; 2018 Dec; 24(1):. PubMed ID: 30597970
[TBL] [Abstract][Full Text] [Related]
18. Variability in glycated albumin levels predicts the progression of diabetic nephropathy.
Park SB; Kim SS; Kim IJ; Nam YJ; Ahn KH; Kim JH; Jeon YK; Kim BH; Song SH; Kwak IS; Lee EK; Kim YK
J Diabetes Complications; 2017 Jun; 31(6):1041-1046. PubMed ID: 28396158
[TBL] [Abstract][Full Text] [Related]
19. Amadori albumin in diabetic nephropathy.
Neelofar K; Ahmad J
Indian J Endocrinol Metab; 2015; 19(1):39-46. PubMed ID: 25593824
[TBL] [Abstract][Full Text] [Related]
20. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
Sany D; Elshahawy Y; Anwar W
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
